In this video from Boston Atrial Fibrillation Symposium 2010, Dr. Vivek Reddy discusses some of the new atrial fibrillation catheter ablation technologies and also talks about non-pharmacological approaches to stroke prevention in afib, such as the Watchman and Lariat suture. Dr. Reddy is the Director of Electrophysiology at Mount Sinai …
Read MoreArchives
In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talks about gender differences in atrial fibrillation treatment and afib stroke risk in women. Dr. Russo is Director of Cardiac Ablation and Arrhythmia Services at Cooper University Hospital (New Jersey) and professor of medicine at Robert Wood …
Read MoreOne of the most common questions we get centers around the use of anticoagulant drugs—either the brand drug, Coumadin, or the generic version, warfarin—and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It's just as …
Read MoreThere was an update today on the long-awaited FDA status of Atritech's WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced …
Read MoreGenetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31%, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots …
Read MoreThis very important story may change how afib patients and their doctors decide if they should be on anticoagulant medications (blood thinners), such as Coumadin or warfarin. The CHADS2 scoring system is how doctors now decide who should be on Coumadin or warfarin to avoid strokes, but a newly-published study adds new stroke risk factors …
Read MoreThe Agency for Healthcare Research and Quality (AHRQ) has introduced a video to help those on anticoagulant drugs, such as Coumadin or warfarin, to use them safely. The video is designed to complement what patients learn from their doctors, pharmacies, or Coumadin clinics. Anticoagulants reduce the risk of stroke in those with atrial fibrillation by …
Read MoreIf you're interested in being part of a clinical research study comparing an investigational drug (a drug that is not FDA-approved) to Coumadin®, please contact: Jay Garcia Novellus Research Sites 11160 Warner Ave, Suite 109 Fountain Valley, CA 92708 714-786-5155
Read MoreWe know that more men than women have atrial fibrillation, but that women have a higher rate of strokes and death. In fact, women account for about 61% of stroke deaths. Recent research at Rush University Medical Center identified nine specific gender differences between women and men who have atrial fibrillation. Those included that women …
Read MoreThis September, StopAfib.org marks the third year of celebrating Atrial Fibrillation Month to raise awareness of atrial fibrillation (afib), an expensive and life-threatening irregular heartbeat that is a common cause of stroke. StopAfib.org founder, Mellanie True Hills, knows the toll that atrial fibrillation takes on those with it and their families. After surviving blood clots …
Read More